FDA gives tentative nod for Alembic's generic LastacaftAlcaftadine ophthalmic solution has a market value of roughly $7 million for the 12 months ended December 2019, according to IQVIA. Zydus Cadila gets FDA OK for BaclofenZydus Cadila's baclofen tablets are available in a dosage strength of 5 mg. Zydus gets tentative OK for generic Opsumit Generic Opsumit tablets will be available in a dosage strength of 10 mg. Amneal launches generic Butrans Butrans had a market value of roughly $225 million for the 12 months ended February 2020, according to IQVIA. Mylan's Robert Coury returns as executive chairman Robert Coury returns to Mylan as executive chairman amid the COVID-19 outbreak, and activities needed to close the combination of Mylan and Upjohn. Dr. Reddy's rolls out 2 generics For the year ended January 2020, Nitroglycerin transdermal patch products had a market value of roughly $14.7 million, and the Evekeo brand and generic had a market value of approximately $38 million. Cipla obtains FDA approval for generic Proventil HFA Cipla’s generic albuterol inhaler is the first generic to treat and prevent bronchospasm. AAM cancels Access! 2020 Annual Meeting AAM has cancelled its annual meeting scheduled for May and is looking forward to GRx+Biosims conference in November. Zydus Cadila’s generic Trilafon obtains FDA approval The FDA has approved Zydus Cadila’s generic Trilafon tablets in four dosage strengths. Aurobindo gets FDA OK for generic Zanaflex Aurobindo's generic Zanaflex will be available in three dosage strengths. First Previous 160 161 162 163 164 Next Last
